Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 EPS Loss of $0.18
Tweet Send to a FriendGet Alerts ISIS Hot Sheet
Price: $20.39 --0%
EPS Growth %: +91.7%
Financial Fact:
Gain (loss) on investments, net: 1.06M
Today's EPS Names:
SFL, RL, PERY, More
EPS Growth %: +91.7%
Financial Fact:
Gain (loss) on investments, net: 1.06M
Today's EPS Names:
SFL, RL, PERY, More
Trade ISIS Now!
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $23.98 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Seaworld Ent. (SEAS) Narrows Q1 Loss to 49c/Share; Guides FY13 Revs
- Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
